Clinical trial
Tricaprilin in Mild to Moderate Alzheimer's Disease
NCT00142805
Study timeline
Study start (actual)2004-11-04Date precision: day
Registry last updated2020-09-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer's Diseaseunresolved
Interventions
TricaprilinDRUG
PlaceboOTHER
Sponsors & collaborators
Cerecinlead sponsor
Mapped research locations
DallasTexas, United States2St. PetersburgFlorida, United States2ChicagoIllinois, United States1San AntonioTexas, United States1TampaFlorida, United States1PortlandOregon, United States1PhoenixArizona, United States1Fort LauderdaleFlorida, United States1RaleighNorth Carolina, United States1HollywoodFlorida, United States1Boca RatonFlorida, United States1Newport BeachCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00142805 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.